EUVIMEDEUVIMED entdecken
Crossref

Neuroinflammation in Severe COVID-19: The Dynamics of Inflammatory and Brain Injury Markers During Hospitalization

Carla Andretta Moreira Neves, Gilson P Dorneles, Paula C Teixeira, Paulo C Santana Filho, Alessandra Peres, Carina Rodrigues Boeck, Liane N Rotta, Claudia E Thompson, Pedro R T Romão

Molecular Neurobiology · 2025

DOI: 10.1007/s12035-024-04551-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Neurobiology, 2025. Verfasst von Carla Andretta Moreira Neves und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cellular and Molecular Immunology, Universidade Federal de Ciências da Saúde de Porto Alegre, Rua Sarmento Leite 245, Porto Alegre, RS,…. Hauptthemen laut MEDLINE: COVID-19, Hospitalization, Neuroinflammatory Diseases, Brain Injuries. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brasil, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Federal University of Health Sciences of Porto Alegre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with COVID-19 can develop excessive inflammation in the brain and consequent neurological complications. The aim of this study was to evaluate the inflammatory, endothelial and brain injury markers in hospitalized COVID-19 patients and compare those with or without neurological symptoms. A total of 30 intensive care unit (ICU) COVID-19 patients were allocated into COVID-19 (without neurological symptoms) or neuro-COVID-19 (with neurological symptoms) groups. Patients with respiratory infection symptoms but negative for COVID-19 were included as a control group. Peripheral blood samples were collected at hospital admission (T1) (controls and ICU patients) and during hospitalization (T2: last 72 h before hospital discharge or in-hospital death) (ICU COVID-19 patients) to analyze inflammatory markers. Higher ICAM-1, CCL26 and VEGF at T1 were identified in both COVID-19 groups compared with control. Neuro-COVID-19 patients presented lower systemic BDNF levels compared with the control group and increased S100B compared with the control and COVID-19 groups. BDNF levels in survivors were lower in the neuro-COVID-19 group compared to the COVID-19 group, while S100B were higher, regardless of the outcome. In addition, all COVID-19 patients presented increased ICAM-1 and CCL26 levels over the hospitalization period (T2 > T1). Furthermore, S100B, ICAM-1, CCL26 and VEGF levels increased in relation to T1 in neuro-COVID-19 patients, with S100B and CCL26 being significantly higher in relation to the COVID-19 group. In conclusion, high levels of brain injury biomarkers were found in patients with neuro-COVID-19, indicating neuroinflammatory and consequent brain injury in the last 72 h of hospitalization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HospitalizationNeuroinflammatory DiseasesBrain InjuriesHumansMaleFemaleMiddle AgedBiomarkersAgedIntercellular Adhesion Molecule-1Brain-Derived Neurotrophic FactorVascular Endothelial Growth Factor ASARS-CoV-2S100 Calcium Binding Protein beta SubunitAdultIntensive Care UnitsInflammation

Stichwörter der Autor:innen

BDNFCCL26Endothelial injuryInflammatory mediatorsS100B

Substanzen

BiomarkersIntercellular Adhesion Molecule-1Brain-Derived Neurotrophic FactorVascular Endothelial Growth Factor AS100 Calcium Binding Protein beta SubunitS100B protein, human

Autor:innen und Institutionen

  • Laboratory of Cellular and Molecular Immunology, Universidade Federal de Ciências da Saúde de Porto Alegre, Rua Sarmento Leite 245, Porto Alegre, RS, 90050-170, Brazil.
  • Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil.
  • Laboratory of Cellular and Molecular Immunology, Universidade Federal de Ciências da Saúde de Porto Alegre, Rua Sarmento Leite 245, Porto Alegre, RS, 90050-170, Brazil. gilsondorneles@gmail.com.
  • Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil. gilsondorneles@gmail.com.
  • Graduate Program in Biosciences, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil.
  • Franciscan University, UFN, Santa Maria, Brazil.

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brasil
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Federal University of Health Sciences of Porto Alegre

Zitieren

APA

Neves, C. A. M., Dorneles, G. P., Teixeira, P. C., Santana Filho, P. C., Peres, A., Boeck, C. R., Rotta, L. N., Thompson, C. E., & Romão, P. R. T. (2025). Neuroinflammation in Severe COVID-19: The Dynamics of Inflammatory and Brain Injury Markers During Hospitalization. Molecular Neurobiology. https://doi.org/10.1007/s12035-024-04551-4

Vancouver

Neves CAM, Dorneles GP, Teixeira PC, Santana Filho PC, Peres A, Boeck CR, et al. Neuroinflammation in Severe COVID-19: The Dynamics of Inflammatory and Brain Injury Markers During Hospitalization. Molecular Neurobiology. 2025. doi:10.1007/s12035-024-04551-4

BibTeX
@article{Neves2025,
  author = {Neves, Carla Andretta Moreira and Dorneles, Gilson P and Teixeira, Paula C and Santana Filho, Paulo C and Peres, Alessandra and Boeck, Carina Rodrigues and Rotta, Liane N and Thompson, Claudia E and Romão, Pedro R T},
  title = {Neuroinflammation in Severe COVID-19: The Dynamics of Inflammatory and Brain Injury Markers During Hospitalization},
  journal = {Molecular Neurobiology},
  year = {2025},
  doi = {10.1007/s12035-024-04551-4}
}
Kostenlos starten →